Ideaya Biosciences Inc. (IDYA) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Ideaya Biosciences Inc. (IDYA:NASDAQ), powered by AI.

Current Price
$30.57
Sector
Healthcare
What is the Ideaya Biosciences Inc. stock price forecast?

Ideaya Biosciences Inc. is currently trading at $30.57. View real-time AI analysis on Alpha Lenz.

What is Ideaya Biosciences Inc. insider trading activity?

View the latest insider trading data for Ideaya Biosciences Inc. on Alpha Lenz.

What is Ideaya Biosciences Inc.'s P/E ratio?

View Ideaya Biosciences Inc.'s valuation metrics on Alpha Lenz.

Ideaya Biosciences Inc.

NASDAQ · IDYA
$30.57+0.34(+1.12%)Pre-marketNASDAQ regular session 09:30–16:00 ET
Ask about Ideaya Biosciences Inc.'s future dividend policy...
Alpha Chat Insight

Ideaya Biosciences Inc.'s ROE is -10.9%. Explore profitability and growth together.

Ask for details

Company Overview

Ideaya Biosciences Inc. is a biotechnology company that focuses on the discovery and development of synthetic lethality-focused cancer therapies. The company excels in integrating precision medicine with immuno-oncology to create therapeutic solutions that target specific genetic and tumor bio-markers. This focus enables Ideaya Biosciences to address unmet medical needs in the oncology sector, providing innovative treatment options for patients with genetically defined cancers. The company’s pipeline features a diverse range of developmental therapies targeting key genetic mutations and alterations associated with various forms of cancer. Through strategic research and development partnerships, Ideaya Biosciences Inc. plays a critical role in advancing the understanding and treatment of cancer, making significant contributions to the biopharmaceutical industry. With its headquarters located in South San Francisco, California, the company is at the forefront of biotechnology innovation, working towards more effective and targeted cancer therapies.

CEOMr. Yujiro S. Hata
SectorHealthcare
IndustryBiotechnology
Employees131

Company Statistics

FY 2025

Profile

N/AMarket Cap
$218.71MRevenue
0.00Shares Out
131Employees

Margins

N/AGross
-70.74%EBITDA
-72.84%Operating
-51.99%Pre-Tax
-51.99%Net

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

62.54%Rev 3Yr
62.11%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-10.18%ROA
-10.92%ROE
-14.27%ROIC

Financial Health

$112.83MCash & Cash Equivalents
$-26.43MNet Debt
8.45%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Ideaya Biosciences Inc. (ticker: IDYA) is a company listed on NASDAQ in the Healthcare sector (Biotechnology). It has approximately 131 employees.

The current price is $30.57 with a P/E ratio of -x and P/B of -x.

ROE is -10.92% and operating margin is -72.84%. Annual revenue is $219M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Ideaya Biosciences Inc. (IDYA) Stock Forecast 2026 $30.57 — Price, Financials & Analyst Targets | Alpha Lenz